Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells

Oncogene

Volumn 28, Issue 46, 2009, Pages 4065-4074

  Song, B ^a   Wang, Y ^a,b   Xi, Y ^c   Kudo, K ^c   Bruheim, S ^d,e   Botchkina, G I ^a   Gavin, E ^c   Wan, Y ^b   Formentini, A ^f   Kornmann, M ^f   Fodstad, O ^d,e   Ju, J ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b WUHAN UNIVERSITY   (China)

^c UNIVERSITY OF SOUTH ALABAMA   (United States)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

^f UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; HISTONE DEACETYLASE 4; METHOTREXATE; MICRORNA; MICRORNA 140; PROTEIN; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CHEMOSENSITIVITY; COLON CANCER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

ANTIMETABOLITES, ANTINEOPLASTIC; BONE NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HCT116 CELLS; HUMANS; METHOTREXATE; MICRORNAS; OSTEOSARCOMA; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 70450237022     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.274     Document Type: Article

References (39)

1. Alvarez-Garcia I, Miska EA. (2005). MicroRNA functions in animal development and human disease. Development 132: 4653-4662.
2. Ambros V, Lee RC. (2004). Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol Biol 265: 131-158.
3. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116: 281-297.
4. Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh Jr MS, Crawford H, Dufour A et al. (2009). Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis. Cancer Genomics Proteomics 6: 19-29.
5. Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T et al. (2008). p53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 68: 10094-10104.
6. Bruheim S, Bruland OS, Breistol K, Maelandsmo GM, Fodstad O. (2004). Human osteosarcoma xenografts and their sensitivity to chemotherapy. Pathol Oncol Res 10: 133-141.
7. Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L et al. (1999). Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 104: 263-269.
8. Calin G, Croce CM. (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
9. Chandar N, Billig B, McMaster J, Novak J. (1992). Inactivation of p53 gene in human and murine osteosarcoma cells. Br J Cancer 65: 208-214.
10. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW et al. (2007). Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104: 10158-10163.
11. Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL. (1988). DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61: 420-427.
12. Du L, Wang H, He L, Zhang J, Ni B, Wang X et al. (2008). CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 14: 6751-6760.
13. Eberharter A, Becker PB. (2002). Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep 3: 224-229.
14. Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA et al. (1999). Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401: 188-193.
15. Georges SA, Biery MC, Kim SY, Schelter JM, Guo J, Chang AN et al. (2008). Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215. Cancer Res 68: 10105-10112.
16. Grozinger C, Schreiber SL. (2002). Deacetylase enzymes: biological functions and the use of small-molecule inhibitors. Chem Biol 9: 3-16.
17. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. (2007). A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134.
18. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P et al. (2007). MicroRNA signatures in human ovarian cancer. Cancer Res 67: 8699-8707.
19. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S. (2009). Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 23: 806-812.
20. Koishi K, Yoshikawa R, Tsujimura T, Hashimoto-Tamaoki T, Kojima S, Yanagi H et al. (2006). Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer. World J Gastroenterol 12: 7585-7590.
21. Kozak M. (2008). Faulty old ideas about translational regulation paved the way for current confusion about how microRNAs function. Gene 423: 108-115.
22. Krishan A. (1975). Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66: 188-193.
23. Laemmli UK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
24. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
25. Moskovits N, Kalinkovich A, Bar J, Lapidot T, Oren M. (2006). p53 attenuates cancer cell migration and invasion through repression of SDF-1/CXCL12 expression in stromal fibroblasts. Cancer Res 66: 10671-10676.
26. Nicolas FE, Pais H, Schwach F, Lindow M, Kauppinen S, Moulton V et al. (2008). Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140. RNA 14: 2513-2520.
27. O'Brien CA, Pollett A, Gallinger S, Dick JE. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110.
28. Pillai RS, Bhattacharyya SN, Fillipowicz W. (2007). Repression of protein synthesis by miRNAs: how many mechanisms? Trends cell Biol 17: 118-126.
29. Plasterk RH. (2006). MicroRNAs in animal development. Cell 124: 877-881.
30. Raver-Shapira N, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z et al. (2007). Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743.
31. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C et al. (2007). Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
32. Sengupta N, Seto E. (2004). Regulation of histone deacetylase activities. J Cell Biochem 93: 57-67.
33. Song B, Wang Y, Kudo K, Gavin EJ, Xi Y, Ju J. (2008). miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res 14: 8080-8086.
34. Tuddenham L, Wheeler G, Ntounia-Fousara S, Waters J, Hajihosseini MK, Clark I et al. (2006). The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett 580: 4214-4217.
35. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
36. Wilson AJ, Byun DS, Nasser S, Murray LB, Ayyanar K, Arango D et al. (2008). HDAC4 promotes growth of colon cancer cells via repression of p21. Mol Biol Cell 19: 4062-4075.
37. Yang XJ, Gregoire S. (2005). Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol Cell Biol 25: 2873-2874.
38. Zhang B, Wang Q, Pan X. (2007). MicroRNAs and their regulatory roles in animals and plants. J Cell Physiol 210: 279-289.
39. Zou GM. (2008). Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver. J Cell Physiol 217: 598-604.